NYSE:ATNM | Operating Income | Actinium Pharmaceuticals, Inc.

Complete source-backed operating income history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$27.57M
2026-03-31-$5.9M
2025-12-31-$6.41M
2025-09-30-$5.69M
2025-06-30-$7.5M
2025-03-31-$16.64M
2024-12-31-$7.51M
2024-09-30-$12.6M
2024-06-30-$12.42M
2024-03-31-$9.6M
2023-12-31-$10.34M
2023-09-30-$14.35M
2023-06-30-$15.64M
2023-03-31-$11.58M
2022-12-31-$11.29M
2022-09-30-$9.8M
2022-06-30-$7.85M
2022-03-31-$5.16M
2021-12-31-$8.05M
2021-09-30-$6.47M
2021-06-30-$5.08M
2021-03-31-$5.37M
2020-12-31-$6.44M
2020-09-30-$5.61M
2020-06-30-$4.66M
2020-03-31-$5.68M
2019-12-31-$4.63M
2019-09-30-$6.65M
2019-06-30-$5.09M
2019-03-31-$5.7M
2018-12-31-$6.36M
2018-09-30-$6.2M
2018-06-30-$4.91M
2018-03-31-$6.35M
2017-12-31-$5.21M
2017-09-30-$6.7M
2017-06-30-$7.2M
2017-03-31-$7.81M
2016-12-31-$6.83M
2016-09-30-$7.1M
2016-06-30-$6.92M
2016-03-31-$6M
2015-12-31-$4.92M
2015-09-30-$4.64M
2015-06-30-$7.4M
2015-03-31-$7.87M
2014-12-31-$6.87M
2014-09-30-$7.04M
2014-06-30-$4.42M
2014-03-31-$4.14M
2013-12-31-$1.48M
2013-09-30-$1.61M
2013-06-30-$1.48M
2013-03-31-$2.02M
2012-12-31-$3.7M
2012-09-30-$2.4M
2012-06-30-$839,339.00
2012-03-31-$1.01M
2011-12-31-$3.28M
2011-09-30-$2,430.00
2010-12-31-$7,235.00

Annual Operating Income

DateOperating Income
2025-12-31-$36.25M
2024-12-31-$42.12M
2023-12-31-$51.92M
2022-12-31-$34.1M
2021-12-31-$24.96M
2020-12-31-$22.39M
2019-12-31-$22.07M
2018-12-31-$23.83M
2017-12-31-$26.91M
2016-12-31-$26.85M
2015-12-31-$24.83M
2014-12-31-$22.48M
2013-12-31-$6.59M
2012-12-31-$7.95M
2011-12-31-$3.28M
2010-12-31-$26,053.00